Back to search
Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neurofibromatosis Type 1-Associated Plexiform Neurofibromas trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neurofibromatosis Type 1-Associated Plexiform Neurofibromas trials you may qualify forBackground: \- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after treatment. Researchers want to see if a d…
This study aims to demonstrate that in subjects with symptomatic, inoperable plexiform neurofibromas associated with neurofibromatosis type 1, TQ-B3234 capsules…
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee, and applicable co…
This study evaluates mirdametinib (PD-0325901) in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas (PNs…
This is a prospective, multicenter, observational study of Chinese pediatric NF1-PN patients treated with selumetinib. The study will be conducted at approximat…